Clinical Trials in Detroit

Showing 1261-1280 of 9,449 trials

A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVÉDERM® Products, KYBELLA, CoolSculpting Elite and SkinMedica Products

NCT06783621

A study to evaluate overall participant satisfaction of face and neck appearance after treatment with onabotulinumtoxinA, JUVÉDERM® products, KYBELLA, CoolSculpting Elite, and select SkinMedica products in a diverse population.

Facial Contouring

AbbVie130 participantsStarted Jan 2025

Redondo Beach, California, United States • Vista, California, United States • Washington D.C., District of Columbia, United States +7 more locations

RECRUITINGPHASE220 miles

A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years

NCT06735248

The primary objective of this trial is to evaluate the safety and reactogenicity of mRNA-1195 in participants with multiple sclerosis.

Multiple Sclerosis

ModernaTX, Inc.180 participantsStarted Apr 2025

Boston, Massachusetts, United States • Farmington Hills, Michigan, United States • Ozark, Missouri, United States +14 more locations

A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVÉDERM® Products, KYBELLA, CoolSculpting Elite and SkinMedica Products

A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years

Find Trials by Condition in Detroit

Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)

A Phase 1/2 Study of AMG 193 in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid Tumors

Ribociclib and Letrozole Treatment in Ovarian Cancer

Study of SX-682 Plus Enzalutamide in Men With ARPI-Resistant Metastatic Castration Resistant Prostate Cancer

ExCrossV Multi Site Trial for Vascularized High Risk Keratoplasty

A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer

Safety and Efficacy of Turoctocog Alfa Pegol (N8-GP) in Previously Untreated Patients With Haemophilia A

Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer

Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B

A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIV

CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old

A Study of AMG 355 Alone and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors

Study of the CycloPen Micro-Interventional System and Long-Term Clinical Outcomes

Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

KYSA-8: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Treatment Refractory Stiff Person Syndrome

SP Thoracic IDE Study

Gene Therapy for Cardiomyopathy Associated With Friedreich's Ataxia